These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6789719)

  • 1. Intranasal nitroglycerin (NTG) during infrarenal aortic cross-clamp.
    Moon GJ; Kim JG; Cookinham FT
    Anesthesiology; 1981 Aug; 55(2):191-2. PubMed ID: 6789719
    [No Abstract]   [Full Text] [Related]  

  • 2. Hemodynamics of intravenous nitroglycerin during aortic clamping.
    Zaidan JR; Guffin AV; Perdue G; Smith R; McNeill DC
    Arch Surg; 1982 Oct; 117(10):1285-8. PubMed ID: 6812549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous nitroglycerin administration during infrarenal aortic clamping.
    Bjoraker DG; Knight PR
    Can Anaesth Soc J; 1984 Jan; 31(1):44-50. PubMed ID: 6420026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects on hemodynamics and myocardial metabolism of nicardipine and nitroglycerin during aortic cross clamp in dogs with experimentally produced coronary stenosis].
    Nomura M; Miura Y; Uchida K; Nagasawa C; Takahashi K; Kawai N; Nomura Y; Fujita M; Suzuki H
    Masui; 1994 Mar; 43(3):321-8. PubMed ID: 8182875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitroglycerin infusion during infrarenal aortic cross-clamping in dogs: an experimental study.
    Peterson A; Brant D; Kirsh MM
    Surgery; 1978 Aug; 84(2):216-23. PubMed ID: 98858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infrarenal aortic cross-clamping and renal hemodynamics.
    Gelman S; Navar LG
    Anesthesiology; 1985 Aug; 63(2):223-4. PubMed ID: 4025874
    [No Abstract]   [Full Text] [Related]  

  • 7. The use of intranasal nitroglycerin to prevent pressor responses during intubation in general anesthesia--a comparison of various doses.
    Hwang JJ; Ko YP; Jen RK; Hsu YW; Cheng CR; Wei TT; Yeh CY
    Acta Anaesthesiol Sin; 1995 Dec; 33(4):205-10. PubMed ID: 8705152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of intravenous trinitroglycerin and nifedipine in surgery of the abdominal aorta].
    De Monte A; Bertolissi M; Muzzi R; Peressutti R; Lumina C; Amigoni S; Giordano F
    Minerva Anestesiol; 1990 Sep; 56(9):1019-21. PubMed ID: 2125710
    [No Abstract]   [Full Text] [Related]  

  • 9. Renal vasoconstriction and transient declamp hypotension after infrarenal aortic occlusion: role of plasma purine degradation products.
    Frank RS; Moursi MM; Podrazik RM; Zelenock GB; D'Alecy LG
    J Vasc Surg; 1988 Apr; 7(4):515-23. PubMed ID: 2895191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intranasal administration of nitroglycerin solution and nitroglycerin spray during general anesthesia].
    Iwasaka H; Kunisaki Y; Yamamoto H; Kitano T; Kinoshita R; Taniguchi K; Honda N
    Masui; 1993 Oct; 42(10):1423-8. PubMed ID: 8230691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of nitroglycerin on ventricular oxygen extraction during aortic occlusion.
    Scott WJ; Gewertz BL
    J Vasc Surg; 1986 Nov; 4(5):505-10. PubMed ID: 3095568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of intravenous nitroglycerin on hemodynamics in infants and children with congestive heart failure.
    Zeng H; Sun L; Li W; Du J
    Chin Med J (Engl); 2000 Apr; 113(4):328-31. PubMed ID: 11775229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitrates in aortic valve disease: acute and chronic effects.
    Tebbe U; Neuhaus KL; Sauer G; Neumann P; Kreuzer H
    Z Kardiol; 1983; 72 Suppl 3():152-5. PubMed ID: 6421006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamics and exercise tolerance during application of transdermal systems with phasic nitroglycerin (NTG) release in comparison to 20 mg isosorbide mononitrate.
    Jansen W; Hinsche A; Rappert B; Geppert R; Tauchert M
    Int J Clin Pharmacol Ther Toxicol; 1992 Nov; 30(11):505-6. PubMed ID: 1490809
    [No Abstract]   [Full Text] [Related]  

  • 15. The reason for cardiac output reduction after aortic cross-clamping.
    Gelman S; McDowell H; Varner PD; Pearson J; Ebert J; Graybar G; Proctor J
    Am J Surg; 1988 Apr; 155(4):578-86. PubMed ID: 3128132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic attenuation and the nitrate-free interval: alternative dosing strategies for transdermal nitroglycerin.
    Flaherty JT
    Am J Cardiol; 1985 Dec; 56(17):32I-37I. PubMed ID: 3000161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of transdermal nitroglycerin in children with congestive heart failure: a Doppler echocardiographic study.
    Vaksmann G; Pariente-Khayat A; Godart F; Francart C; Rey E; D'Athis P; Pons G; Rey C
    Pediatr Cardiol; 2001; 22(1):11-3. PubMed ID: 11123120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infrarenal aortic clamping and renal hemodynamics.
    Abadir AR; Chou SY; Gintautas J; Tadoori PR
    Proc West Pharmacol Soc; 1987; 30():333-7. PubMed ID: 3628301
    [No Abstract]   [Full Text] [Related]  

  • 19. Intranasal nitroglycerin and intraocular pressure during general anesthesia.
    Mahajan RP; Grover VK; Sharma SL; Singh H
    Anesth Analg; 1988 Jul; 67(7):631-6. PubMed ID: 3132868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential hemodynamic effects and tolerance properties of nitroglycerin and an S-nitrosothiol in experimental heart failure.
    Bauer JA; Fung HL
    J Pharmacol Exp Ther; 1991 Jan; 256(1):249-54. PubMed ID: 1899118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.